US 12,137,716 B2
Methods of liver disease treatment
Michael Hudnall, Scottsdale, AZ (US)
Filed by Michael Hudnall, Scottsdale, AZ (US)
Filed on Nov. 16, 2021, as Appl. No. 17/527,919.
Application 17/527,919 is a continuation in part of application No. 15/681,529, filed on Aug. 21, 2017, granted, now 11,252,984.
Application 15/681,529 is a continuation of application No. 14/688,400, filed on Apr. 16, 2015, abandoned.
Prior Publication US 2022/0071257 A1, Mar. 10, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A23L 33/105 (2016.01); A23L 33/00 (2016.01); A23L 33/10 (2016.01); A23L 33/15 (2016.01); A23L 33/16 (2016.01); A23L 33/175 (2016.01); A23L 33/18 (2016.01); A61K 31/198 (2006.01); A61K 31/525 (2006.01)
CPC A23L 33/105 (2016.08) [A23L 33/00 (2016.08); A23L 33/10 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A61K 31/198 (2013.01); A61K 31/525 (2013.01); A23V 2002/00 (2013.01)] 18 Claims
OG exemplary drawing
 
1. A method of reducing liver fibrosis comprising the steps of
administering a composition to a patient, the composition comprising:
a cysteine-providing ingredient in a range of 500-5,000 mg;
polyenylphosphatidylcholine in a range of 500-10,000 mg;
alpha lipoic acid in a range of 200-2,500 mg; and
at least one of: L-lysine in a range of 400-5,000 mg; L-arginine in a range of 1,000-9,000 mg; vitamin C in a range of 500-10,000 mg; N-acetyl L-carnitine in a range of 250-3,000 mg; betaine HCl in a range of 300-20,000 mg; L-glutamate in a range of 200-2,000 mg; turmeric in a range of 200-1,500 mg; proanthocyanidins in a range of 100-1,000 mg; nigella sativa in a range of 50-400 mg; pantothenic acid in a range of 20-10,000 mg; magnesium in a range of 50-800 mg; vitamin E in a range of 50-1,000 IU; cynara scolymus in a range of 25-300 mg; L-glycine in a range of 50-3000 mg; vitamin B1 in a range of 10-200 mg; vitamin B2 in a range of 10-200 mg; ubiquinol in a range of 30-1,000 mg; piper cubeba in a range of 10-100 mg; vitamin B3 in a range of 45-3,000 mg; vitamin B6 in a range of 10-200 mg; zinc in a range of 5-50 mg; vitamin D3 in a range of 400-10,000 IU; folate in a range of 200-3,000 mcg; vitamin B12 in a range of 200-3,000 mcg; selenium in a range of 100-600 mcg; vitamin A in a range of 200-3,000 μg retinol activity equivalents; Vitamin K in a range of 30-5,000 mcg; and biotin in a range of 50-2,000 mcg;
wherein the administering is repeated every 24 hours; and
testing the patient, the step of testing comprising taking a sample from the patient, analyzing the sample for an indicator of liver fibrosis, and comparing the analyzed sample to a previously analyzed sample.